Evidence map›Paper›PMID 37762484›Full record

ReviewInternational journal of molecular sciences2023

Modeling Myotonic Dystrophy Type 2 Using

Marta Marzullo, Sonia Coni, Assia De Simone, Gianluca Canettieri, Laura Ciapponi

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Myotonic dystrophies: an update on clinical features, molecular mechanisms, management, and gene therapy.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  4. Decoding Nucleotide Repeat Expansion Diseases: Novel Insights fromInternational journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Marta MarzulloDepartment of Biology and Biotechnologies "C. Darwin", Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0001-7229-1693
Sonia ConiDepartment of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0002-0295-8904
Assia De SimoneDepartment of Biology and Biotechnologies "C. Darwin", Sapienza University of Rome, 00185 Rome, Italy.
Gianluca CanettieriDepartment of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0001-6694-2613
Laura CiapponiDepartment of Biology and Biotechnologies "C. Darwin", Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-0817-1862
Sapienza University of Rome · ITIstituto Pasteur · IT

Funding

Telethon Foundation GMR22T1027
6 · The paper itself

Abstract

Myotonic dystrophy 2 (DM2) is a genetic multi-systemic disease primarily affecting skeletal muscle. It is caused by CCTGn expansion in intron 1 of the

Indexed as

Drosophila ProteinsMyotonic DystrophyAnimalsDrosophilaDrosophila melanogasterIntronsMuscle, SkeletalRNA-Binding ProteinsCNBP protein, DrosophilaDrosophila ProteinsRNA-Binding ProteinsCNBPDM2Drosophila melanogastermyotonic dystrophy type 2

Identifiers

PMID37762484
PMCPMC10532015
OpenAlexW4386814801

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.